Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001209191-16-112919

SVP, Chief Business Officer sold 1,401 shares at $9.41 ($13,183)

From the SEC's structured data for this filing

Trades in this filing

Dahan Michel · SVP, Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-04-04 Sale : show line 1 in the form −1,401 $9.41 $13,183 74,956 D
Open-market sales · 1,401 sh · avg $9.41 · $13,183
Loading xslF345X03/doc4.xml…